Press Release

CD BIOPARTICLES INTRODUCES FUNCTIONAL AGAROSE PARTICLES FOR BIOMEDICAL RESEARCH APPLICATIONS



CD Bioparticles Introduces Functional Agarose Particles for Biomedical Research Applications

FOR IMMEDIATE RELEASE

28/06/2024

With years of experience in the pharmaceutical and life science sectors, CD Bioparticles proudly announces the launch of its new Functional Agarose Particles designed for a variety of applications in the field of bioconjugation, isolation, and purification of biomacromolecules. These particles are ideal for researchers working in areas such as protein purification, antibody production, and nucleic acid isolation.

CD Bioparticles offers a range of functional agarose particles that can be used to covalently capture tagged biomolecules, such as tagged proteins, or to immobilize proteins and antibodies. They can also serve as hydrophobic chromatographic separation media, immobilized metal ion affinity chromatography resins, ion exchange chromatography resins, etc., which are suitable for conjugation of antibodies, streptavidin, enzymes and nucleic acids to activated agarose particles. They also play a critical role in the production of recombinant proteins and the purification of monoclonal antibodies. They are an important carrier tool in molecular biology and medical research, and their importance extends to biopharmaceutical and industrial engineering applications.

The new functional agarose particles are available with a variety of functional groups, including hydrophobic, ion exchange, and affinity chromatography groups. This allows researchers to choose the particles that best suit their specific needs. For example, the hydrophobic interaction chromatography (HIC) separation particles (functionalized with butyl, phenyl, octyl) can be utilized to separate proteins based on their hydrophobicity, while the immobilized metal affinity chromatography (IMAC) particles (functionalized with Al-NTA, Co2+, Co-IDA, Co-NTA, Cu-NTA, Fe-NTA, IDA, Ni2+, Ni-IDA, etc.) can be used to purify and enrich proteins such as His-tagged proteins.

In addition, agarose particles functionalized with DEAE, sulfopropyl, carboxymethyl, quaternary ammonium can be used as IEC resins with high ion exchange capacity and less nonspecific adsorption, which can be applied in the laboratory preparation of biomolecules such as proteins, nucleic acids and peptides. Activated agarose particles (functionalized with azide, alkyne, methyltetrazine, TCO, disulfide, etc.) can also be used for coupling of biomolecules.

The new functional agarose particles are available in a variety of sizes, ranging from 25 µm to 400 µm. In addition to their wide range of functionalities and sizes, these functional agarose particles offer a unique combination of properties that make them ideal for a broad range of applications, including excellent chemical stability, high yield and customizability. These particles can selectively bind to specific biomolecules, and this targeted binding capability streamlines the purification process, reducing time and effort for researchers.

CD Bioparticles' Functional Agarose Particles are available in a variety of configurations to meet the specific needs of each research project. These particles offer superior efficiency and selectivity, enabling researchers to achieve faster and more accurate results. The company also offers custom bead development services to create particles tailored to unique applications. For more information, please visit https://www.cd-bioparticles.com/products/functional-agarose-particles-1065.html.

About CD Bioparticles

CD Bioparticles is a leading manufacturer and supplier of various nanoparticles, microparticles, and coatings for R&D as well as commercialization across different application areas, including in vitro diagnostics, biochemistry, cellular analysis, cell separation, and immunoassay. The company also offers various custom services, including chemical surface-functionalization, fluorescent modification, antibody immobilization, as well as nucleic acid and oligo conjugation to meet client specifications.

Tags:
Functional Agarose Particles  |  CD Bioparticles  |  

---

Organisation Profile:
CD Bioparticles is an established drug delivery company which provides customized solutions for developing and producing new, biocompatible drug delivery systems.






Press release contact details for CD Bioparticles

NameCD Bioparticles
Tel1-631-346-0027
Fax
Email
Websitehttps://www.cd-bioparticles.net/
OrganisationCD Bioparticles
Address
Town
County0
Postcode




Other press releases from CD Bioparticles

CD Bioparticles Launches Gene Silencing for Bio-research Application
CD Bioparticles Launches Gel Permeation Chromatography Resins
CD Bioparticles Introduces Reversed Phase Chromatography Resins for Biological Analysis
CD Bioparticles Launches mRNA Transfection Reagents for Research Applications
CD Bioparticles Launches Normal Phase Chromatography Resins for Chromatographic Analysis
CD Bioparticles Launches 3D Transfection Reagents for Bio-research Applications
CD Bioparticles Launches Affinity Chromatography Resins for Laboratory Usage
CD Bioparticles Announces Carrageenans for Scientific Applications
CD Bioparticles Launches New Chromatography Resins for Improved Analysis and Preparation of Chiral Compounds
CD Bioparticles Launches New Alginic Acids for Research Applications
CD Bioparticles Launches Locust Bean Gum for Biopharmaceutical Applications
CD Bioparticles Announces New PLGA-Based Drug Delivery Systems for In Vitro and In Vivo Applications
CD Bioparticles Launches New Line of Bioinks for 3D Bioprinting
CD Bioparticles Launches New Quantum Dots Labeling & Conjugation Kits
CD Bioparticles Introduces New Extraction and Purification Kits for Rapid and Reliable DNA Isolation
CD Bioparticles Launches New Tissue Engineering Scaffolds for Researchers
CD Bioparticles Launches New Line of Polystyrene Particles Conjugated with Biomolecules
CD Bioparticles Launches 3D Cell Culture Substrate for Bio-research
CD Bioparticles Announces the Launch of New Flow Cytometry Particles
CD Bioparticles Introduces the Launch of Engineered Tissue Scaffolds
CD Bioparticles Announces Polyamino Acids for Drug Delivery Applications
CD Bioparticles Launches New Line of Functional Polystyrene Particles
CD Bioparticles Announces Expanded Offerings of Polydimethylsiloxane for Cutting-Edge Research
CD Bioparticles Unveils Versatile Plain Polystyrene Particles for Diverse Bioresearch Applications
CD Bioparticles Launches New Range of Low PDI Polymers for Drug Delivery Applications
CD Bioparticles Launches New Line of Particles for Solid Phase Organic Synthesis
CD Bioparticles Introduces Innovative Agarose Particles for Purification of Proteins and Antibodies
CD Bioparticles Announces New Line of Polyacrylamides for Drug Delivery Studies
CD Bioparticles Announces Versatile Basic Agarose Particles for Efficient Biomolecule Separation
CD Bioparticles Introduces New Polyolefin Family Polymers for Drug Delivery Applications
CD Bioparticles Announces New Line of Conjugated Agarose Particles for Affinity Separation and Purification
CD Bioparticles Announces Offering of Polystyrene Family Polymers for Drug Delivery
CD Bioparticles Announces Comprehensive Assay Portfolio for mRNA-LNP Vaccine Development
CD Bioparticles Introduces Functional Agarose Particles for Biomedical Research Applications
CD Bioparticles Announces Advanced Capabilities in Customized Liposomes for Targeted Delivery
CD Bioparticles Simplifies Multi-Analyte Detection with Advanced Multiplex Particles
Endotoxin Free Gold Nanoparticles for Biomedical Research and Bioassay Development
CD Bioparticles Introduces Innovative Agonist-Based Adjuvants for Enhanced Vaccine Efficacy

Disclaimer:
Issuers of the press releases are solely responsible for the content of their press releases. Connect2business.co.uk cannot be held liable for the content posted by others to this website.